MedPath
HSA Approval

HIZIN 25 TABLET 25 mg

SIN03422P

HIZIN 25 TABLET 25 mg

HIZIN 25 TABLET 25 mg

June 16, 1989

UNI DRUG HOUSE

UNI DRUG HOUSE

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantUNI DRUG HOUSE
Licence HolderUNI DRUG HOUSE

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

N05BB01

hydroxyzine

Manufacturer Information

UNI DRUG HOUSE SDN. BHD.

OLIC (THAILAND) LTD

Active Ingredients

HYDROXYZINE HCl

25 mg

Hydroxyzine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

HIZIN 25 TABLET 25 mg - HSA Approval | MedPath